National Psoriasis Foundation

Drug Pipeline

« Back to the pipeline

Company

Maruho Co. Ltd.

Therapeutic Approach

Topical Treatments

Indication

Psoriasis

Mechanism

anti-inflammatory/skin cell inhibitor (proprietary)

Phase

Phase III

Get the latest research news and tips on managing your psoriasis and psoriatic arthritis.